• The Children First

    Lilines Urriola Herrera, medcom
    medcom

    In the past year, Panama has made some important and positive headlines worldwide. The country was awarded an investment grade credit rating by both of the globally renown ratings agencies, Fitch Ratings and Standard and Poor’s. Also, the New York Times named Panama as the number one travel destination in 2012. The country also had economic growth of 8 percent from 2006 to 2010, and in 2011 the country’s economy grew 10.6 percent, making it one of the fastest-growing economies in Latin America.  more[...]  login_required

    The Author
     
  • Wellness for All: Thinking Globally, Acting Locally

    Novo Nordisk
    Scott Dille, Novo Nordisk

    NovoHealth is a worldwide company program seeking to develop a workplace culture that promotes and supports healthy living for all employees – an opportunity for Novo Nordisk to practice what we preach. NovoHealth inspires healthy living among Novo Nordisk employees as a means to prevent Type 2 diabetes and other lifestyle-driven diseases. NovoHealth gives us an exciting opportunity to bring the organization together across the globe, support our colleagues, address our social responsibility as an employer, and improve business performance.  more[...]  login_required

    The Author
     
  • Towards an ´Energy Plus´ - Approach for the Poor

    United Nations Development Programme (UNDP)

    New analysis from the United Nations Development Programme (UNDP), based on case studies from across Asia and the Pacific, calls for a set of 'energy plus” services – one that combines access to modern energy for heating, cooking and electricity, with measures that generate cash, supplement incomes and improve health and education.  more[...]  login_required

    The Author
     
  • Providing Know-how

    Mireille Cayreyre, Sanofi Aventis

    Accessibility and availability of products are as well as the training of good heath care professionals the key problems in rural areas in Africa. We talked about that with Mireille Cayreyre from Sanofi-Aventis.  more[...]  login_required

    The Author
    Mireille Cayreyre, Sanofi Aventis 
     
  • Early Origins of Health

    Editorial Team

    The global community is beginning to understand the enormity of the humanitarian, societal, and economic challenge that noncommunicable diseases (NCDs) present. The rates of diabetes, cardiovascular disease, cancer, and chronic respiratory diseases are rapidly increasing in almost all countries such that these are now among the world’s biggest killers. There is a growing recognition that the development of these diseases may have their roots in our earliest days of life within the uterine environment and up to the age of two years and that early intervention is a cost-effective means of preventing NCDs later in life. Therefore, pregnancy offers a unique window of opportunity to turn the tide of the NCD epidemic.  more[...]  login_required

    The Author
    Editorial Team
     
  • Early Origins of Health

    Scott Dille, Novo Nordisk
    Novo Nordisk

    The global community is beginning to understand the enormity of the humanitarian, societal, and economic challenge that noncommunicable diseases (NCDs) present. The rates of diabetes, cardiovascular disease, cancer, and chronic respiratory diseases are rapidly increasing in almost all countries such that these are now among the world’s biggest killers. There is a growing recognition that the development of these diseases may have their roots in our earliest days of life within the uterine environment and up to the age of two years and that early intervention is a cost-effective means of preventing NCDs later in life. Therefore, pregnancy offers a unique window of opportunity to turn the tide of the NCD epidemic.  more[...]

    The Author
     
  • Attacking a Potential Killer of Children

    Editorial Team

    In 2006, Merck introduced RotaTeq®, its rotavirus vaccine, in the U.S. Merck recognized, however, that this vaccine was most needed in the developing world but that it would be unsustainable to donate it on an ongoing basis – it needed to identify a sustainable business model. Through the Merck-Nicaraguan Ministry of Health RotaTeq® Partnership Merck pledged to donate enough rotavirus vaccine for three birth cohorts of children and funding to introduce the vaccine, improve disease awareness, develop appropriate educational materials, and update the routine vaccination card. Our goal was to demonstrate the feasibility and health benefit of introducing the vaccine in a developing country.  more[...]  login_required

    The Author
    Editorial Team
     
  • Attacking a Potential Killer of Children

    Dr. Barbara J. Kuter, Merck
    Maggie M. Kohn, Merck
    Merck

    In 2006, Merck introduced RotaTeq®, its rotavirus vaccine, in the U.S. Merck recognized, however, that this vaccine was most needed in the developing world but that it would be unsustainable to donate it on an ongoing basis – it needed to identify a sustainable business model. Through the Merck-Nicaraguan Ministry of Health RotaTeq® Partnership Merck pledged to donate enough rotavirus vaccine for three birth cohorts of children and funding to introduce the vaccine, improve disease awareness, develop appropriate educational materials, and update the routine vaccination card. Our goal was to demonstrate the feasibility and health benefit of introducing the vaccine in a developing country.  more[...]

    The Author
     
  • ACI Contributes Where Others Do Not

    Editorial Team

    Following its core values, ACI seeks to play a part in improving the quality of people’s lives through the creation of new jobs and offerings services to people. Based on this belief, the Medical Information and Research Team as well as the Medical Services Department of ACI Pharmaceuticals partnered with CARE Bangladesh – an international development agency – to initiate a healthcare project under the name Amar Shasthya, which stands for “my health.”  more[...]  login_required

    The Author
    Editorial Team
     
  • ACI Contributes Where Others Do Not

    Muallem A. Choudhury, Advanced Chemical Industries (ACI)
    Dr. Rumana Dowla, ACI Pharmaceuticals
    ACI Limited

    Following its core values, ACI seeks to play a part in improving the quality of people’s lives through the creation of new jobs and offerings services to people. Based on this belief, the Medical Information and Research Team as well as the Medical Services Department of ACI Pharmaceuticals partnered with CARE Bangladesh – an international development agency – to initiate a healthcare project under the name Amar Shasthya, which stands for “my health.”  more[...]

    The Author
     
  • Sustainable Ship Recycling in Bangladesh

    Editorial Team

    The aim of the project is to focus on the current problems related to environment, health, safety, and social aspects of the ship recycling industry in Bangladesh. As part of the project, TÜV Rheinland conducts awareness-building programs and helps companies to build capacity as well as optimize their work techniques so that they comply with international standards and best practices.  more[...]  login_required

    The Author
    Editorial Team
     
  • Sustainable Ship Recycling in Bangladesh

    Kokila A.N., TÜV Rheinland Group

    The aim of the project is to focus on the current problems related to environment, health, safety, and social aspects of the ship recycling industry in Bangladesh. As part of the project, TÜV Rheinland conducts awareness-building programs and helps companies to build capacity as well as optimize their work techniques so that they comply with international standards and best practices.  more[...]

    The Author
    Kokila A.N., TÜV Rheinland Group 
     
  • Improving the Future of Epileptic Patients

    Mireille Cayreyre, Sanofi Aventis
    Sanofi

    Epilepsy is not a cause of significant mental impediments. Nevertheless, it is often falsely perceived as a mental disorder in developing countries. Although epilepsy is not fatal, patients who do not receive treatment will experience serious difficulties over their lifetime. In addition to the disease being a handicap in daily life and work, over time, people with epilepsy face social marginalization or even exclusion. In turn, the social group itself is deprived of their economic and social contributions. To address this disease in developing countries, all of these factors need to be taken into account. Sanofi-aventis, as a leader in the global pharmaceutical industry, is thus providing developing countries not only facilitated access to its quality medicines, but also a large number of health services that respond to their specific needs. Epilepsy is not a cause of significant mental impediments. Nevertheless, it is often falsely perceived as a mental disorder in developing countries. Although epilepsy is not fatal, patients who do not receive treatment will experience serious difficulties over their lifetime. In addition to the disease being a handicap in daily life and work, over time, people with epilepsy face social marginalization or even exclusion. In turn, the social group itself is deprived of their economic and social contributions. To address this disease in developing countries, all of these factors need to be taken into account. Sanofi-aventis, as a leader in the global pharmaceutical industry, is thus providing developing countries not only facilitated access to its quality medicines, but also a large number of health services that respond to their specific needs.  more[...]

    The Author
     
  • Working Together on Safety

    Editorial Team

    Autostrade per l’Italia has always been committed to an effective policy of accident prevention through the empowerment of workers and companies. In addition to the strict observance of rules regarding safety at work provided for by the legislative decree no. 81, Consolidated Health and Safety at Work, on April 9, 2008, the company carries out training of workers and also finances enhanced training programs. In addition to the requirements of the law, it identifies standards of self-regulation and, above all, establishes an ongoing dialogue with governments, regulatory institutions, and associations within the industry.  more[...]  login_required

    The Author
    Editorial Team
     
 
 
 
 

Partners


GCYB

SBA

CSR Manager Logo

 empty

 empty

 

 

 

 

 

Supporters


BMAS

    ESF 

empty


 empty

 

 

 

 

 

About Us // Privacy Policy // Copyright Information // Legal Disclaimer // Contact

Copyright © 2012-2018 macondo publishing GmbH. All rights reserved.
The CSR Academy is an independent learning platform of the macondo publishing group.